HeartCore Enterprises, Inc.
Close on Oct 19, 2026
- Market cap
- $2.16M
- P/E (TTM)
- 0.3
- Dividend yield
- –
Earnings
Next report expected Nov 17, 2026, before market open (estimated from past report dates)
| Quarter | Reported | Time | Revenue | EPS (GAAP) | EPS (adjusted) |
|---|---|---|---|---|---|
| Q2 FY2026 Ended Jun 30, 2026 | Aug 13, 2026 | Before market open | – | – | – |
| Q1 FY2026 Ended Mar 31, 2026 | May 15, 2026 | Before market open | $1.20M | $-1.49 | – |
| Q4 FY2025 Ended Dec 31, 2025 | Feb 11, 2026 | Before market open | – | – | – |
| Q3 FY2025 Ended Sep 30, 2025 | Nov 18, 2025 | Before market open | $3.00M | – | – |
| Q2 FY2025 Ended Jun 30, 2025 | Aug 13, 2025 | During market hours | $4.70M | – | – |
| Q1 FY2025 Ended Mar 31, 2025 | May 15, 2025 | Before market open | $3.60M | $-0.14 | – |
| Q4 FY2024 Ended Dec 31, 2024 | Mar 31, 2025 | Before market open | – | – | – |
| Q3 FY2024 Ended Sep 30, 2024 | Oct 18, 2024 | Before market open | – | – | – |
| Q2 FY2024 Ended Jun 30, 2024 | Aug 14, 2024 | Before market open | – | – | – |
| Q1 FY2024 Ended Mar 31, 2024 | Apr 8, 2024 | During market hours | – | – | – |
| Q3 FY2023 Ended Sep 30, 2023 | Nov 13, 2023 | Before market open | – | – | – |
Company guidance
Outlook given with results on Feb 11, 2026, compared with the previous outlook
| Measure | Period | Guidance | vs. prior |
|---|---|---|---|
| Net income | FY 2025 | $3.00M to $4.00M | New |
| Revenue | FY 2025 | $8.50M to $9.50M | New |
Figures and the sentence they come from are taken from the company's earnings release. Hover a measure to read the source sentence.
Press releases
Announcements HeartCore Enterprises filed with the SEC
Reports Second Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Announces Strategic Transfer of 51% Equity Interest in HeartCore Luvina Vietnam to Luvina Software
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
Completes Strategic Divestiture of Sigmaways
Material agreement · Acquisition or disposition completed · Regulation FD disclosure · EX-99.1 to Form 8-K
Reports First Quarter 2026 Financial Results
Results of operations · EX-99.1 to Form 8-K
Regains Compliance with Nasdaq Minimum Bid Price Requirement
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Announces 1-for-20 Reverse Stock Split
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Reports Full Year 2025 Results
Results of operations · EX-99.1 to Form 8-K
Authorizes $2.0 Million Share Repurchase Program as Part of Disciplined Capital Allocation Strategy
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Announces Preliminary Fiscal Year 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2025
Results of operations · EX-99.1 to Form 8-K
Granted 180-Day Extension to Regain Compliance with Nasdaq’s Minimum Bid Price Requirement
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Divests Software Business Subsidiary, HeartCore Co., Ltd
Material agreement · Acquisition or disposition completed · Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Clarifies Form of One-Time Payment to Stockholders
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
to Authorize One-Time Dividend Payment
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT ISSUED ON AUGUST 28, 2025
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT ISSUED ON AUGUST 18, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT DATED AUGUST 13, 2025
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT ISSUED ON JULY 2, 2025
Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE ISSUED BY THE REGISTRANT ON JULY 1, 2025
Material agreement · Unregistered share sale · Charter or bylaw amendment · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT ISSUED ON JUNE 25, 2025
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT ISSUED ON JUNE 3, 2025
Material agreement · Regulation FD disclosure · EX-99.1 to Form 8-K
HeartCore Reports First Quarter 2025 Financial Results
Results of operations · EX-99.1 to Form 8-K
PRESS RELEASE OF THE REGISTRANT ISSUED ON MARCH 31, 2025
Results of operations · EX-99.1 to Form 8-K
OF THE COMPENSATION COMMITTEE OF
Other events · EX-99.1 to Form 8-K
Nominating and Corporate Governance Committee (the “Committee”) of the Board of Directors (the “Board”) of Heartcore
Other events · EX-99.2 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Reports Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Regains Compliance with Nasdaq Listing Requirements
Regulation FD disclosure · EX-99.1 to Form 8-K
Expands its CMS Platform Offering into a SaaS Delivery Model
Regulation FD disclosure · EX-99.1 to Form 8-K
Notice of Press Release Announcing HeartCore’s Expansion of its CMS Platform Offering into a SaaS Delivery Model
Regulation FD disclosure · EX-99.2 to Form 8-K
to Appeal Nasdaq Delisting Notice
Regulation FD disclosure · EX-99.1 to Form 8-K
Announces Preliminary Third Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Go IPO Client, SBC Medical Group, Begins Trading on the Nasdaq Stock Exchange
Regulation FD disclosure · EX-99.1 to Form 8-K
EX-99.1 to Form 8-K
Regulation FD disclosure · EX-99.1 to Form 8-K
Reports Second Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
to Authorize Second Dividend Payment
Regulation FD disclosure · Other events · EX-99.1 to Form 8-K
Reports First Quarter 2024 Financial Results
Results of operations · EX-99.1 to Form 8-K
Provides Update on March Go IPO Warrant Sale and Encouraging Outlook
Regulation FD disclosure · EX-99.1 to Form 8-K
Signs 14 th Go IPO Contract
Results of operations · EX-99.1 to Form 8-K
Reports Full Year 2023 Results and Provides Strategic Priorities for 2024
Results of operations · EX-99.1 to Form 8-K